India, April 27 -- Abbott (ABT) announced data from the AVEIR Conduction System Pacing acute clinical feasibility study, which demonstrated the safety and performance of the investigational AVEIR Conduction System Pacing leadless pacemaker technology.
The AVEIR Conduction System Pacing acute clinical feasibility study is the world's first assessment of a leadless pacemaker delivering conduction pacing to the heart's left bundle branch (LBB) area. Conduction System Pacing (CSP) is a novel pacing approach that targets the LBB area by enabling pacing that mimics the heart's natural electrical rhythm.
The AVEIR CSP acute clinical feasibility study demonstrated successful implantation of the AVEIR CSP leadless pacemaker deep into the wall sepa...